Home › Research › Topics › psen1
psen1
5 studies tagged psen1, dated 2010-07-14 to 2020-02-04. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations 2020-02-04
- A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio 2019-01-01
- A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation 2017-01-01
Studies
5 studies carry this tag.
Date range
2010 to 2020
Top journals
- Journal of Alzheimer's disease : JAD 2
- Alzheimer's research & therapy 1
- European journal of human genetics : EJHG 1
- Neurobiology of disease 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Mutations in APP (amyloid precursor protein), PSEN1 (presenilin 1) or PSEN2 (presenilin 2) are the main cause of early-onset familial forms of Alzheimer's disease (autosomal dominant AD or ADAD).
-
The novel PSEN1 M139L mutation found in familial AD increases the Aβ42/Aβ40 ratio significantly.
-
The K311R mutation might contribute to AD pathogenesis by overproducing toxic Aβ species and enhancing tau phosphorylation.
-
We found pathogenic mutations in PSEN1, GRN and MAPT in 2.33% of the screened cases.
-
Early-onset dominantly inherited forms of Alzheimer's disease (AD) are rare, but studies of such cases have revealed important information about the disease mechanisms.